ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

kite pharma eu b.v. - axicabtagene ciloleucel - lymphoma, follicular; lymphoma, large b-cell, diffuse - daganatellenes szerek - yescarta is indicated for the treatment of adult patients with diffuse large b cell lymphoma (dlbcl) and high-grade b-cell lymphoma (hgbl) that relapses within 12 months from completion of, or is refractory to, first-line chemoimmunotherapy. yescarta is indicated for the treatment of adult patients with relapsed or refractory (r/r) dlbcl and primary mediastinal large b cell lymphoma (pmbcl), after two or more lines of systemic therapy. yescarta is indicated for the treatment of adult patients with r/r follicular lymphoma (fl) after three or more lines of systemic therapy.

ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

alfasigma s.p.a. - metil-tionin-klorid - colorectal neoplasms; colonoscopy - other diagnostic agents - lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.

ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

kite pharma eu b.v. - autologous peripheral blood t cells cd4 and cd8 selected and cd3 and cd28 activated transduced with retroviral vector expressing anti-cd19 cd28/cd3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) - lymphoma, mantle-cell - daganatellenes szerek - mantle cell lymphomatecartus is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (mcl) after two or more lines of systemic therapy including a bruton’s tyrosine kinase (btk) inhibitor. acute lymphoblastic leukaemiatecartus is indicated for the treatment of adult patients 26 years of age and above with relapsed or refractory b-cell precursor acute lymphoblastic leukaemia (all).

হাঙ্গেরি - হাঙ্গেরীয় - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

s.a.l.f. s.p.a. laboratorio farmacologico - adrenalin (adrenalin) -

ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

bioprojet pharma - pitolisant - sleep apnea, obstructive - egyéb idegrendszeri gyógyszerek - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).

হাঙ্গেরি - হাঙ্গেরীয় - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

hameln pharma gmbh - noradrenalin -

ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

janssen-cilag international nv - ciltacabtagene autoleucel - myeloma multiplex - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

হাঙ্গেরি - হাঙ্গেরীয় - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

alk-abelló a/s - epinephrine bitartrate -

হাঙ্গেরি - হাঙ্গেরীয় - OGYÉI (Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetről)

alk-abelló a/s - epinephrine bitartrate -

ইউরোপীয় ইউনিয়ন - হাঙ্গেরীয় - EMA (European Medicines Agency)

roche registration gmbh  - glofitamab - lymphoma, large b-cell, diffuse - daganatellenes szerek - columvi as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl), after two or more lines of systemic therapy.